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Abstract 
Recurrent fever is frequent among children and mostly associated with viral infections inocu-
lated via social contacts with others of the same age. Rarely, severe conditions such as hema-
tological malignancies, pediatric rheumatoid diseases, chronic infections, or inherited recurrent 
fever syndromes are causative. Herein, we present the case of an 11-year-old boy with fre-
quently recurring high-fever episodes since early childhood, failure to thrive, and iron defi-
ciency who was found to have classical celiac disease (CD) with highly elevated tissue transglu-
taminase and anti-gliadin antibodies and marked duodenal villous atrophy. Upon implemen-
tation of a gluten-free diet, the boy ceased to have fevers, antibodies decreased markedly, his 
iron status improved, and he significantly gained weight. Although infrequent, recurrent fever 
should be included into the polymorphic clinical picture of CD, and the threshold of testing for 
diagnostic antibodies should be low in such patients. © 2019 The Author(s) 
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Background 
Fever in infancy or childhood is frequent and predominantly related to viral or bacterial 
infections, and only rarely associated with systemic diseases [1]. However, if fevers occur re-
petitively, in a prolonged fashion, or even in a periodic manner, the differential diagnosis is 
wide and comprises malignancies [2], immunodeficiency syndromes or autoimmune diseases 
[3], as well as periodic fever syndromes [4]. The diagnostic workup to reach a correct diagno-
sis is important in these patients for the implementation of an effective treatment, but often it 
is complicated, time-consuming, and frequently requires the referral to specialized pediatric 
centers. 
Herein, we present a case of a 10-year-old boy who had recurrent episodes of high fever 
since the age of 2 years, with normal intellectual development and physical skills but mild 
growth retardation. 
Case Presentation 
An 11-year-old boy was seen by us with repetitive episodes of 5–6 days of agonizing fever 
above 40°C since the early childhood at an irregular frequency of approximately 7–8 times a 
year. Apart from the fever, no other clinical complaints such as gastrointestinal symptoms in-
cluding diarrhea, arthralgia, respiratory symptoms, or skin lesions occurred. No overt nutrient 
intolerance was noticed. At several occasions, detailed workups for infectious causes by the 
family’s general practitioner had unveiled no pathogen. The boy’s pharyngeal tonsils were 
found enlarged on various occasions but never showed deposits. During infancy, the boy had 
undergone the usual vaccination schedules as recommended. The fever periods were treated 
with paracetamol and usually subsided after 5–6 days. During fever episodes, the boy was 
unable to attend school, but during the asymptomatic intervals, he was generally energetic, 
able to perform well as a football player and showed intellectual abilities clearly above the 
average. However, a noticeable sign was a relatively small physical size of the boy compared 
to his 4-year-younger brother and his tall parents. 
At the age of 10 years, the fever episodes became more frequent and showed extended 
lengths of up to 8–10 days, and less responsiveness to antipyretics, which prompted the par-
ents to seek for specialized pediatric attention at the local university hospital as the boy turned 
11 years. There, physical examination revealed a body weight of 24 kg (13.5 percentile, –1.13 
standard deviation [SD]), a BMI of 14.03, and height 130.8 cm (29.6 percentile, –0.37 SD). 
Other physical findings were unremarkable. Common and rare causes of recurrent fevers 
were ruled out, including malaria, various autoimmune diseases such as eosinophilia syn-
dromes, mastocytosis, infantile rheumatoid arthritis, vasculitis, hematological malignancies 
such as acute leukemia, and periodic fever syndromes. At a second referral, rare recurrent 
fever syndromes such as hyper-IgD syndrome by assuring normal IgD and IgA levels, and tu-
mor necrosis factor receptor-associated periodic syndrome and cryopyrin-associated peri-
odic syndrome were ruled out. To obtain a second opinion, the boy was also referred to an-
other university center, which attained similar inconclusive results. At this stage, the parents 
were advised to treat the fevers with corticosteroids (prednisolone at 1 mg/kg body weight), 
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which were necessary 4 times within the next 12 weeks, with a declining response at every 
episode.  
At each of the consultations, the sole pathological findings were elevated levels of C-reac-
tive protein, iron deficiency, and mild microcytic anemia, which was interpreted in the context 
of chronic or repetitive inflammation, although serum ferritin levels were also below normal. 
Routine laboratory tests at first presentation and at the time of establishing the diagnosis are 
shown in Table 1. 
At this time, iron deficiency and microcytic anemia prompted testing for antibodies 
against tissue transglutaminase (anti-tTGA), which was found markedly elevated at 93 kU/L 
(upper limit of normal [ULN] 7 KU/L). Next, an upper gastrointestinal endoscopy was per-
formed, which revealed a markedly atrophied duodenal mucosa, but no other abnormalities 
in the esophagus and stomach. Duodenal biopsies showed a strikingly atrophic duodenal mu-
cosa with marked intraepithelial lymphocytosis, crypt hyperplasia, and villous atrophy com-
patible with grade IIIb according to the modified Marsh-Oberhuber classification (Fig. 1a, b) 
[5]. With these findings, the diagnosis of pediatric CD was established, and the boy was sub-
jected to a strict gluten-free diet after instructing his parents. During short-term follow-up, 
fever episodes stopped instantly and completely until the patient was last seen. Serum levels 
of anti-tTGA declined markedly to 9 kU/L (ULN 7) and of anti-EMA to 1 U/L (ULN 7), reflecting 
compliance with the dietary requirements. Iron stores recovered following oral iron supple-
mentation, and hemoglobin levels increased to high normal values. The boy gained weight of 
6 kg during 12 months after the diagnosis of CD had been established and reported that his 
fatigue and weakness had completely disappeared. A follow-up endoscopy with duodenal bi-
opsies revealed a fully recovered mucosal brush border with no evidence of inflammation or 
duodenal atrophy (Fig. 2a, b). 
Discussion and Conclusion 
We herein present an unusual case of CD in a child who showed episodes of high fever 
since early childhood as the only clinical sign of his underlying disease, and mild anemia and 
iron deficiency as the key finding leading to the correct, although remarkably delayed, specific 
laboratory workup and endoscopic examination allowing for the correct diagnosis and spe-
cific treatment. A strict gluten-free diet allowed the fever episodes to abate and eventually 
terminate, while immunological features of CD and biochemical findings of iron deficiency and 
anemia normalized.  
CD is a life-long systemic immune disorder in genetically susceptible individuals triggered 
by exposure to gluten and its related prolamins contained in wheat, barley, oat, and rye. The 
classical clinical presentation comprises diarrhea, abdominal pain, and distension, growth re-
tardation, and numerous extraintestinal, often dermatological manifestations [6, 7]. The enig-
matic clinical presentation of CD is well known [8–10], but fever as the isolated clinical symp-
tom is rare and has been described only in a few pediatric cases associated with hemophago-
cytic lymphohistiocytosis, which responded well to a gluten-free diet [11, 12]. 
Pathophysiologically, fever results from the production and release of proinflammatory 
cytokines with pyrogenic activity such as interleukin-1, interleukinL-6, tumor necrosis fac-
tor-α, and interferons. Pyrogenic mediators, in particular prostaglandin E2, generated from 
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arachidonic acid in cell membranes, act on the anterior hypothalamus in the central nervous 
system and raise the set point for temperature followed by processes that elevate body tem-
perature. The immunological dysfunction underlying CD is that of an aberrant T-helper cell 1 
(Th1) and 2 (Th2) recruitment. This leads to the activation of autoreactive Th cells followed 
by the subsequent release of proinflammatory cytokines [13], which in turn activate intraep-
ithelial lymphocytes that cause histological mucosal damage in the duodenum [14]. 
Another hypothesis as to how pyrogenic mediators may induce fever in CD is related to 
zonulin, the only known physiological modulator of mucosal integrity by modulating the pa-
tency of tight junctions. Increased zonulin levels cause a loss of the mucosal barrier function 
and allow the entry of intestinal contents such as dietary components, bacterial lipopolysac-
charides, and endotoxins that may function as proinflammatory stimulators in the liver and 
other organs. Interestingly, increased levels of zonulin have been reported in patients with CD 
[15, 16] with gliadin as a potent inducer of zonulin release [17]. However, in our patient, an 
immune-mediated mechanism of pyrexia seems more likely as the fever episodes terminated 
abruptly once a gluten-free diet had been established. If a mucosal barrier dysfunction would 
have been pivotal for the precipitation of fever in our patient, symptoms should have persisted 
since mucosal damage is not expected to heal so quickly. 
In our view, the latency until a correct diagnosis had been reached in this young patient 
is remarkable, but not entirely surprising considering the plethora of symptoms by which CD 
can present initially. In 2007, the Canadian Celiac Association reported the clinical presenta-
tion of 2,681 patients with biopsy-proven celiac disease with the most common features being 
abdominal pain (83%), diarrhea (76%), and weight loss (69%). Failure to diagnose CD was 
often due to ascribing the symptoms to anemia (40%), stress (31%), and irritable bowel syn-
drome (29%). The latter may well explain the reported delay of 11.7 years until the correct 
diagnosis was made in this cohort study, mainly due to misinterpretation and trivialization of 
symptoms [18]. 
Considering the high prevalence of CD in the United States and in most Western and Mid-
dle Eastern countries of approximately 1% [19], and of >3% in patients with iron-deficiency 
anemia [20], the threshold for serological testing for CD should be low, particularly since an-
tibody testing is now widely available and relatively affordable. 
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Fig. 1. a Histology image showing the duodenum prior to gluten-free nutrition at the time of diagnosis of 
CD. Clearly visible is the profound villous atrophy. Hematoxylin-eosin staining. Magnification, 1:100. b Cor-
responding immunohistology using monoclonal CD8 antibodies demonstrating invasion of intraepithelial 
lymphocytes. Magnification, 1:200. 
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Fig. 2. a Histology image showing the duodenum following 18 months of strict gluten-free diet. Villous 
atrophy is no longer visible. Hematoxylin-eosin staining. Magnification, 1:100. b Immunohistology from 
the same mucosal specimen using monoclonal CD8 antibodies following 18 months of strict gluten-free 
diet. Only scarce CD8 positivity can be detected. Magnification, 1:100. 
 
 
 
 
Table 1. Laboratory examinations at diagnosis and after 18 months of gluten-free diet 
   
   
Variable (normal range) TP1 TP2 
   
   
Hb (135–175 g/L) 107 132 
Hct (0.41–0.53 L/L) 0.32 0.40 
MCV (77–95 fL) 72 81 
Serum iron (4.4–35.6 μmol/L) 4.3 10.5 
Ferritin (30–300 μg/L) 23 113 
Transferrin saturation (16–45%) 9 19 
CRP (<10 mg/L) 95 0.6 
Anti-tTGA (<10 kU/L) 93 9 
Anti-gliadin IgA (<7 U/L) nd 1 
ALT (<41 U/L) 15 19 
   
   
ALT, alanine aminotransferase, anti-tTGA, anti-tissue 
transglutaminase; CRP, C-reactive protein; Hb, hemoglobin; Hct, 
hematocrit; MCV; mean corpuscular volume; nd, not done; TP1, time 
point 1 (diagnosis); TP2, time point 2 (treatment follow-up). 
 
 
 
 
 
